Abstract
In a current review about pharmacogenomics studies in Brazil, authors showed that there are several retrospectives studies focusing on the drugs and genes. However, no prospective analyses of drug therapy outcomes or cost-effectiveness assessments of pharmacogenomics-guided therapy were found at 2018. Last years, we organized lab logistics and clinical multidisciplinary professional to pe…